跳至主要内容
临床试验/NCT01710696
NCT01710696已完成3 期

Induction of Puberty With 17-Beta Estradiol in Girls With Turner Syndrome. An Open Randomized Trial

Novo Nordisk A/S1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 1998年7月23日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
50
试验地点
1
主要终点
Pubertal stage assesed by Tanner score

研究概览

简要总结

This trial is conducted in Europe. The aim of the trial is to induce normal pubertal development in girls with Turner Syndrome in accordance with that of their peers and their individual state psychosocial maturation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

性别
Female
接受健康志愿者

入选标准

  • Turner Syndrome
  • Treatment with growth hormone
  • Bone age minimum 12 years and maximum 14 years
  • Clear signs of ovarian insufficiency
  • Well documented growth rate during the last 12 months

排除标准

  • Signs of spontaneous puberty
  • Known or suspected hypersensitivity to trial product
  • Acute or chronic liver disease
  • Previous treatment with estrogen
  • Undiagnosed abnormal genital bleeding
  • Known thyroid diseases not adeadequately treated
  • Porphyria

研究组 & 干预措施

Individual dose

Experimental

干预措施: 17-beta estradiol (Drug)

Fixed dose

Experimental

干预措施: 17-beta estradiol (Drug)

结局指标

主要结局

Pubertal stage assesed by Tanner score

FSH (Follicle Stimulating Hormone) levels

次要结局

  • Height velocity
  • Pubertal stage assessed by Tanner score: Breast, pubic hair, axillary hair
  • Adverse events

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验